Susceptibility profile of vaginal yeast isolates from Brazil

Mycopathologia

Volumn 151, Issue 1, 2001, Pages 5-10

  Ribeiro, M A ^a   Dietze, R ^a   Paula, C R ^b   Da Matta, D A ^b   Colombo, A L ^b  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antifungal susceptibility; Candida spp; Vaginitis

Indexed keywords

ANTIFUNGAL AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BRAZIL; CANDIDA; CANDIDA ALBICANS; CLASSIFICATION; DRUG EFFECT; FEMALE; HUMAN; IMMUNOCOMPETENCE; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PREVALENCE; STANDARD; VAGINA; VAGINA CANDIDIASIS; VULVOVAGINITIS;

ANTIFUNGAL AGENTS; BRAZIL; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; IMMUNOCOMPETENCE; MICROBIAL SENSITIVITY TESTS; PREVALENCE; VAGINA; VULVOVAGINITIS;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA;

EID: 0034914137     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010909504071     Document Type: Article

References (23)

1. Candidal vulvovaginitis
2. Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis
3. Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with Human Immunodeficiency Virus
4. Current concepts: Vaginitis
5. Immunopathogenesis of recurrent vulvovaginal candidiasis
6. Candida glabrata, Review of epidemiology, pathogenesis and clinical disease with comparison to Candida albicans
7. Vulvovaginitis due to Candida glabrata. An emerging problem
8. Fluconazole-resistant candidosis in an HIV cohort
9. Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients
10. Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in human immunodeficiency virus-infected patients
11. Development of interpretative break-points for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole and Candida infections
12. Correlation of in vitro susceptibility test results with clinical response: A study of azole therapy in AIDS patients
13. Immune compromised and prevalence of Candida vulvovaginitis in human immunodeficiency virus-infected women
14. Vaginitis in sexually active women: Relationships to nine sexually transmitted organisms
15. Genital yeast infections
16. Prevalence of and risk factors for fungal vaginitis caused by non-albicans species
17. Drug resistance in human pathogenic fungi
18. Azole drug resistance in yeast
19. Candida albicans resistance in AIDS
20. Resistance of Candida species to fluconazole
21. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: Evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen